Methicillin resistance patterns associated with peritonitis in a university-based peritoneal dialysis center

Peritoneal Dialysis International

Volumn 19, Issue 5, 1999, Pages 483-486

  Mason, Nancy A ^a   Zhang, Tongqing ^b   Messana, Joseph M ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM; CEFAZOLIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; METICILLIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PERITONITIS; CLINICAL TRIAL; GRAM POSITIVE BACTERIUM; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PENICILLIN RESISTANCE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0033372248     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089901900514     Document Type: Article

References (12)

1. Keane WF, Alexander SR, Bailie GR, Boeschoten E, Gokal R, Golper TA, et al. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int 1996; 16:557-63.
2. CDC recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR CDC Surveill Summary 1995; 44(No. RR-12).
3. Staphylococcus aureus with reduced susceptibility to vancomycin -United States, 1997. MMWR Morb Mortal Weekly Rep 1997; 46:765-6.
4. Vas SI. VRE and empirical vancomycin for CAPD peritonitis: use at your own/patient's risk. Perit Dial Int 1998; 18:86-7.
5. Van Biesen W, Vanholder R, Vogelaers D, Peleman R, Verschraegen G, Vijt D, et al. The need for a center-tailored treatment protocol for peritonitis. Perit Dial Int 1998; 18:274-81.
6. Alves FR, Dantas RC. Is the treatment of beta lactam sensitive infections (BLSI) without vancomycin (Vc) possible (Abstract)? Perit Dial Int 1997; 17(Suppl 1):S27.
7. Lai, MN, Kao MT, Chen CC, Cheung SY, Chung WK. Intraperitoneal once-daily dose of cefazolin and gentamicin for treating CAPD peritonitis. Perit Dial Int 1997; 17:87-9.
8. Vas S, Bargman J, Oreopoulos DG. Treatment in PD patients of peritonitis caused by gram-positive organisms with single daily dose of antibiotics. Perit Dial Int 1997; 17:91-4.
9. Weber J, Staerz E, Mettang T, Machleidt C, Kuhlmann U. Treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) with intraperitoneal cefazolin and gentamicin. Perit Dial Int 1989; 9:191-5.
10. Golper T. Intermittent versus continuous antibiotics for PD-related peritonitis. Perit Dial Int 1997; 17:11-12.
11. Bunke CM, Brier ME, Golper TA. Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int 1997; 52:524-9.
12. Sandoe JAT, Gokal R, Struthers JK. Vancomycin-resistant enterococci and empirical vancomycin for CAPD peritonitis. Perit Dial Int 1997; 17:617-18.